LN3506249
EMPA , ≥98% , 1832-53-7
Synonym(s):
N-Ethyl-2-[(6-methoxy-3-pyridinyl)[(2-methylphenyl)sulfonyl]amino]-N-(3-pyridinylmethyl)-acetamide
| Pack Size | Price | Stock | Quantity |
| 10mg | RMB4236.00 | In Stock |
|
| 50mg | RMB17896.00 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 106-107 °C |
| Density | 1.172 g/mL at 25 °C(lit.) |
| refractive index | n |
| Flash point: | >230 °F |
| storage temp. | -20°C |
| solubility | Chloroform (Slightly), Methanol (Slightly) |
| form | Oil |
| pka | 2.31±0.10(Predicted) |
| color | Colourless |
| Merck | 13,3595 |
| Stability: | Moisture Sensitive |
| InChI | InChI=1S/C3H9O3P/c1-3-6-7(2,4)5/h3H2,1-2H3,(H,4,5) |
| InChIKey | UFZOPKFMKMAWLU-UHFFFAOYSA-N |
| SMILES | P(C)(=O)(O)OCC |
Description and Uses
EMPA is a novel high-affinity, selective antagonist for the OX2 receptor.
Safety
| Symbol(GHS) |  GHS06 |
| Signal word | Danger |
| Hazard statements | H301-H315-H319-H335 |
| Precautionary statements | P301+P310+P330-P302+P352-P305+P351+P338 |
| Hazard Codes | T,F |
| Risk Statements | 25-36/37/38-39/23/24/25-23/24/25-11 |
| Safety Statements | 26-36-45-36/37-16 |
| RIDADR | UN 2810 6.1/PG 3 |
| WGK Germany | 3 |
